ConvaTec Group plc ADR (CNVVY)

Currency in USD
13.10
-0.41(-3.03%)
Closed·
CNVVY Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
CNVVY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.4713.31
52 wk Range
10.7716.65
Key Statistics
Prev. Close
13.51
Open
12.47
Day's Range
12.47-13.31
52 wk Range
10.77-16.65
Volume
13.45K
Average Volume (3m)
74.26K
1-Year Change
0%
Book Value / Share
0.83
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNVVY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.80
Upside
+5.34%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

ConvaTec Group plc ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

ConvaTec Group plc ADR Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for used in continuous infusion treatments for conditions such as Parkinson’s disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Compare CNVVY to Peers and Sector

Metrics to compare
CNVVY
Peers
Sector
Relationship
P/E Ratio
34.6x25.8x−0.5x
PEG Ratio
0.730.000.00
Price/Book
3.9x2.1x2.6x
Price / LTM Sales
2.9x2.4x3.2x
Upside (Analyst Target)
5.3%10.4%41.4%
Fair Value Upside
Unlock20.8%6.0%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 13.80
(+5.34% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.09%
Dividend Yield
1.65%
Industry Median 1.34%
Annualised payout
0.22
Paid unevenly
5-Years Growth
+2.39%
Growth Streak

Earnings

Latest Release
May 23, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CNVVY Income Statement

FAQ

What Stock Exchange Does ConvaTec ADR Trade On?

ConvaTec ADR is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for ConvaTec ADR?

The stock symbol for ConvaTec ADR is "CNVVY."

What Is the ConvaTec ADR Market Cap?

As of today, ConvaTec ADR market cap is 6.58B.

What Is ConvaTec ADR's Earnings Per Share (TTM)?

The ConvaTec ADR EPS (TTM) is 0.09.

When Is the Next ConvaTec ADR Earnings Date?

ConvaTec ADR will release its next earnings report on 28 Jul 2025.

From a Technical Analysis Perspective, Is CNVVY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has ConvaTec ADR Stock Split?

ConvaTec ADR has split 0 times.

How Many Employees Does ConvaTec ADR Have?

ConvaTec ADR has 10489 employees.

What is the current trading status of ConvaTec ADR (CNVVY)?

As of 27 Jul 2025, ConvaTec ADR (CNVVY) is trading at a price of 13.10, with a previous close of 13.51. The stock has fluctuated within a day range of 12.47 to 13.31, while its 52-week range spans from 10.77 to 16.65.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.